What is the treatment for tinea pedis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Tinea Pedis

For uncomplicated tinea pedis, topical terbinafine 1% cream applied twice daily for 1 week is the recommended first-line treatment due to its superior efficacy compared to longer courses of other antifungal agents. 1, 2

First-Line Topical Treatment Options

  • Terbinafine 1% cream applied twice daily for 1 week is more effective than longer courses of other antifungal agents, with mycological cure rates of 93.5% at 4 weeks 1, 2
  • Ciclopirox olamine 0.77% cream/gel applied twice daily for 4 weeks achieves approximately 60% clinical and mycological cure at end of treatment, and 85% two weeks after treatment 1, 3
  • Clotrimazole 1% cream applied twice daily for 4 weeks is less effective than terbinafine but is widely available over-the-counter, with mycological cure rates of 73.1% at 4 weeks 1, 2

Treatment Algorithm for Tinea Pedis

  1. For mild to moderate interdigital tinea pedis:

    • Start with topical terbinafine 1% cream twice daily for 1 week 1, 4
    • Continue treatment until at least 1 week after clinical clearing of infection 5
  2. For severe disease, failed topical therapy, or immunocompromised patients:

    • Oral terbinafine 250 mg once daily for 1 week (faster clinical resolution than topical treatments) 1, 6
    • Oral itraconazole 100 mg daily for 2 weeks (similar efficacy to terbinafine but slightly higher relapse rate) 1, 3
    • Oral griseofulvin 0.5g daily (125 mg four times daily, 250 mg twice daily, or 500 mg once daily) for 4-8 weeks for adults 7
    • For children over 2 years: griseofulvin 10 mg/kg daily in divided doses 7

Special Considerations

  • Concomitant use of appropriate topical agents is usually required with oral therapy, particularly in treatment of tinea pedis 7
  • Griseofulvin will not eradicate bacterial or yeast infections that may be present alongside dermatophytes in some forms of tinea pedis 7
  • Risk factors for tinea pedis include swimming, running, warm humid environments, male gender, obesity, and diabetes 1, 3
  • Failing to treat all infected family members simultaneously can result in reinfection 1

Prevention Measures

  • Apply foot powder after bathing to reduce tinea pedis rates from 8.5% to 2.1% 1
  • Thoroughly dry between toes after showering 1, 3
  • Change socks daily and clean athletic footwear periodically 1
  • Cover active foot lesions with socks before wearing underwear to prevent spread to the groin area 1
  • Address contaminated footwear as a potential source of reinfection 1

Treatment Monitoring

  • The definitive endpoint for adequate treatment should be mycological cure, not just clinical response 3
  • Consider follow-up with repeat mycology sampling at the end of the standard treatment period 3
  • Clinical relapse will occur if the medication is not continued until the infecting organism is eradicated 7

Common Pitfalls

  • Treating only until clinical improvement rather than complete mycological cure can lead to recurrence 3, 7
  • Neglecting to address contaminated footwear as a source of reinfection can lead to recurrence 1
  • Using griseofulvin for non-dermatophyte infections (e.g., bacterial infections, candidiasis) will be ineffective as it only works against dermatophytes 7
  • Using topical steroids alone without antifungal agents can worsen the infection 5

References

Guideline

Treatment of Tinea Pedis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Tinea Corporis and Tinea Pedis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Topical terbinafine. Reduction of duration of therapy for tinea pedis].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2008

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.